Index of Mechanisms


Oncology

Miscellaneous

All mechanism

Biologic agents

Monoclonal antibody

Chemotherapy

Anthracyclines based regimen

Capecitabine containing-regimen

Chemotherapy

Combination chemotherapy with platinum salts

Gemcitabine containg regimen

High dose chemotherapy

Induction chemotherapy

Ixabepilone based chemotherapy

Maintenance chemotherapy

Nontaxane microtubule dynamics inhibitor

Taxanes

Vinorelbine containing regimen

Endocrine therapy

Selective estrogen receptor modulator (SERM)

Aromatase inhibitors

LHRH agonist

Selective estrogen receptor downregulators (SERDs)

Immunotherapy

Immune checkpoint inhibition

Immunotherapy

Surgery

Locoregional treatment of the primary tumor

Targeted therapy

AKT Inhibitors

ALK inhibitors

Angiogenesis inhibitors

Cyclin inhibitors

EGFR inhibitors

FGFR inhibitors

HER2 inhibitors

Histone deacetylase (HDAC) inhibitors

MTOR inhibitor

Multi target TKI

Phosphoinositide 3-kinase inhibitor

Poly ADP-ribose polymerase (PARP) inhibitor


Cardiology

ACAT inhibition

Active compression-decompression CPR

Agents to slow down human AAA-expansion

Alpha-glucosidase inhibitors

Anti hypertensive agents

Anti inflammatory drugs

Anti-anginal drugs

Antiarrythmic drugs

Antibiotics

Antioxydants

Atrial natriuretic peptide

Beta-blockers

Bioresorbable vascular scaffold

Calcium channel blockers

Calcium sensitiser

CEPT inhibition

Complement inhibition

Compression-only CPR

Death and events prevention

Diet

Dietary salt reduction

Digitalis glycosides

Endothelin receptor antagonist

Exercise Therapy

Fibrinolysis

Glucose insulin potassium

Hormonal replacement therapy

HR-slowing agents

Increasing hemoglobin concentration

Increasing hemoglobin concentration

Intensive therapy

Lifestyle intervention

Miscellaneous

Modified resuscitation protocol

New drug under development

Nitrates

Omega-3 fatty acids

Oxygen therapy

Phosphodiesterase III inhibitors

Plasma homocysteine lowering intervention

Polypill

Preconditioning

Prevention

Primary prevention of sudden death

Proton-pump inhibitors

Rate control

Relaxin

Relaxine

Restenosis prevention

Rythm control

Screening for CAD

Secondary prevention

Transcatheter aortic-valve implantation (TAVI)

Transmyocardial revacularization

Vasodilators therapy

Vasopeptidase inhibitor

Vasopressin

Vasopressin antagonist

All mechanism

HDL increasing drugs

Intensive blood pressure control

Positive inotropic agent

angiotensin renin system blockade

Angiotensin renin system blockade

Angiotensin-Converting Enzyme Inhibitors

Angiotensin-receptor blockers

Combined inhibition of ACE and neprilysin

Inhibition of the renin-angiotensin system (ACEI or ARB)

Renin inhibitor

anticoagulant

Anticoagulant

Direct antithrombins

Direct factor Xa inhibitors

Direct oral anticoagulant (DAO)

Antidiabetic agents

Antidiabetic drugs

Antidiabetic drugs added to metformin

Glucose lowering for cardiovascular prevention

Insulin secretagogues

Insulin secretagogues - DPP-4 inhibitors

Insulin secretagogues - Meglitinides (glinides)

Insulin secretagogues - sulfonylureas

Insulin secretagogues peptides (incretins)

Insulin sensitizer

Insulin sensitizer - biguanides

Insulin sensitizers - glitazones

Insulin sensitizers - PPAR modulator

Insulin therapy

Intensive glycemic control

SGLT2 inhibitors

antiplatelets

Antiplatelets drug

Dual antiplatelet therapy

New P2Y12 Inhibitors

antithrombotics

Antithrombotics

Heparin (UFH or LMWH)

LMWH

Pentasaccharide

UFH

cholesterol lowering drugs

Cholesterol lowering intervention

Niacin

PCSK9 Inhibitors

Statin

Devices

Catheter ablation

Catheter ablation of ventricular tachycardia

Caval filter

Embolic protection

Endarterectomy

Endovascular treatment

Foramen ovale closure

Graduated compression stockings

ICD

Mechanical devices for thromboprophylaxis

Pacemaker

Percutaneous left ventricular assist device

Percutaneous left ventricular assist devices

Public Access Defibrillation

Resynchronization (CRT) - defibrillators (ICD)

Spinal cord stimulation

Thrombectomy

Ultrafiltration

Diuretics

Aldosterone blockade

Diuretics

Mineralocorticoid receptor antagonists

non drug treatment

BNP guided management

Telemonitoring

PCI

Angioplasty

Drug eluting stent

Fractional-flow-reserve-guided PCI

Intravascular Brachytherapy

Late revascularisation

Myocardial revascularization

PCI

Pre treatment for PCI

Radial access

regenerative therapy

Cell-based therapies

Regenerative therapy

Surgery

Off-pump CABG

Radial graft

Surgery

Vein grafts pretreatment

weight-loss drugs

Weight-loss drugs